Abstract

Abstract: Background Rheumatoid arthritis is currently seen as the primary surgical indication for total elbow arthroplasty (TEA). Nevertheless, surgical indications continue to expand accounting for greater TEA case volumes. Despite evolving trends, very few data describes complications associated with specific surgical indication of TEA. Methods We analyzed The American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database for individuals that received a TEA from 2006 to 2015. Surgical indications and 30-day postoperative complication data for patients treated as inpatients at participating hospitals was obtained. Results 317 patients were identified for analysis. 22.1% of individuals received TEA for rheumatoid arthritis. 52 total adverse events were reported for all patients undergoing TEA. Rheumatoid arthritis patients experienced significantly lower rates of overall adverse events (8.57% versus 18.62%, p= 0.045). Conclusion Rheumatoid arthritis patients that undergo TEA are significantly less likely to develop a 30 day post-operative complication than patients who receive TEA for other reasons.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call